• Return to Headlines

Shares of Loxo Oncology In Has Risen Above Previous 52-Week High

By Nick Russo

Loxo Oncology In (NASDAQ:LOXO) traded today at a new 52-week high of $165.81. So far today approximately 1.1 million shares have been exchanged, as compared to an average 30-day volume of 147,000 shares.

Loxo Oncology In (NASDAQ:LOXO) is currently priced 4.2% above its average consensus analyst price target of $154.83. The stock should discover initial support at its 50-day moving average (MA) of $23.30 and subsequent support at its 200-day MA of $23.15.

Loxo Oncology, Inc. researches and develops cancer drugs. The company focuses on building small molecule cancer drugs for genetically defined patient subsets.

Over the past year, Loxo Oncology In has traded in a range of $17.14 to $165.81 and is now at $161.65, 843% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 1.5%.

SmarTrend is monitoring the recent change of momentum in Loxo Oncology In. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Loxo Oncology In in search of a potential trend change.

Keywords: 52 week high/lows loxo oncology in

Ticker(s): LOXO